 | • レポートコード：MRC2Q12-17104 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥735,000 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,470,000 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、細胞血管新生アッセイのグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 細胞血管新生アッセイのアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 細胞血管新生アッセイの中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 細胞血管新生アッセイのヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの細胞血管新生アッセイの生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の細胞血管新生アッセイの売上および2028年までの予測に焦点を当てています。 細胞血管新生アッセイのグローバル主要企業には、Abcam、Bio-Techne、Thermo Fisher、Cell Biolabs, Inc.、BioVision, Inc、PromoCell GmbH、Merck KGaA、Kollodis BioSciences、Sartorius (Essen BioScience)、Creative Bioarrayなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 細胞血管新生アッセイ市場は、タイプとアプリケーションによって区分されます。世界の細胞血管新生アッセイ市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 生体外アッセイキット、生体内アッセイキット 【アプリケーション別セグメント】 学術機関、バイオテクノロジー企業 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 細胞血管新生アッセイ製品概要 - タイプ別市場（生体外アッセイキット、生体内アッセイキット） - アプリケーション別市場（学術機関、バイオテクノロジー企業） - 調査の目的 ・エグゼクティブサマリー - 世界の細胞血管新生アッセイ販売量予測2017-2028 - 世界の細胞血管新生アッセイ売上予測2017-2028 - 細胞血管新生アッセイの地域別販売量 - 細胞血管新生アッセイの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別細胞血管新生アッセイ販売量 - 主要メーカー別細胞血管新生アッセイ売上 - 主要メーカー別細胞血管新生アッセイ価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（生体外アッセイキット、生体内アッセイキット） - 細胞血管新生アッセイのタイプ別販売量 - 細胞血管新生アッセイのタイプ別売上 - 細胞血管新生アッセイのタイプ別価格 ・アプリケーション別市場規模（学術機関、バイオテクノロジー企業） - 細胞血管新生アッセイのアプリケーション別販売量 - 細胞血管新生アッセイのアプリケーション別売上 - 細胞血管新生アッセイのアプリケーション別価格 ・北米市場 - 北米の細胞血管新生アッセイ市場規模（タイプ別、アプリケーション別） - 主要国別の細胞血管新生アッセイ市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの細胞血管新生アッセイ市場規模（タイプ別、アプリケーション別） - 主要国別の細胞血管新生アッセイ市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の細胞血管新生アッセイ市場規模（タイプ別、アプリケーション別） - 主要国別の細胞血管新生アッセイ市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の細胞血管新生アッセイ市場規模（タイプ別、アプリケーション別） - 主要国別の細胞血管新生アッセイ市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの細胞血管新生アッセイ市場規模（タイプ別、アプリケーション別） - 主要国別の細胞血管新生アッセイ市場規模（トルコ、サウジアラビア） ・企業情報 Abcam、Bio-Techne、Thermo Fisher、Cell Biolabs, Inc.、BioVision, Inc、PromoCell GmbH、Merck KGaA、Kollodis BioSciences、Sartorius (Essen BioScience)、Creative Bioarray ・産業チェーン及び販売チャネル分析 - 細胞血管新生アッセイの産業チェーン分析 - 細胞血管新生アッセイの原材料 - 細胞血管新生アッセイの生産プロセス - 細胞血管新生アッセイの販売及びマーケティング - 細胞血管新生アッセイの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 細胞血管新生アッセイの産業動向 - 細胞血管新生アッセイのマーケットドライバー - 細胞血管新生アッセイの課題 - 細胞血管新生アッセイの阻害要因 ・主な調査結果 |
Cell based angiogenesis assays to analyze new blood vessel formation for applications of cancer research, tissue regeneration and vascular biology.
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Cell Angiogenesis Assay estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Cell Angiogenesis Assay is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Cell Angiogenesis Assay is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Cell Angiogenesis Assay is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key companies of Cell Angiogenesis Assay include Abcam, Bio-Techne, Thermo Fisher, Cell Biolabs, Inc., BioVision, Inc, PromoCell GmbH, Merck KGaA, Kollodis BioSciences and Sartorius (Essen BioScience), etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Cell Angiogenesis Assay companies, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Cell Angiogenesis Assay market. Further, it explains the major drivers and regional dynamics of the global Cell Angiogenesis Assay market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Abcam
Bio-Techne
Thermo Fisher
Cell Biolabs, Inc.
BioVision, Inc
PromoCell GmbH
Merck KGaA
Kollodis BioSciences
Sartorius (Essen BioScience)
Creative Bioarray
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
Cell Angiogenesis Assay Segment by Type
In Vitro Assay Kit
In Vivo Assay Kit
Cell Angiogenesis Assay Segment by Application
Academic Institution
Biotech Companies
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Cell Angiogenesis Assay market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Cell Angiogenesis Assay market size. Analyses of the global market trends, with historic market revenue data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Cell Angiogenesis Assay, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Cell Angiogenesis Assay, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Cell Angiogenesis Assay revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Cell Angiogenesis Assay market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Cell Angiogenesis Assay revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Abcam, Bio-Techne, Thermo Fisher, Cell Biolabs, Inc., BioVision, Inc, PromoCell GmbH, Merck KGaA, Kollodis BioSciences and Sartorius (Essen BioScience), etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Cell Angiogenesis Assay in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cell Angiogenesis Assay companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country/region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cell Angiogenesis Assay revenue, gross margin, and recent development, etc.
Chapter 12: Analyst’s Viewpoints/Conclusions
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell Angiogenesis Assay Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 In Vitro Assay Kit
1.2.3 In Vivo Assay Kit
1.3 Market by Application
1.3.1 Global Cell Angiogenesis Assay Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Academic Institution
1.3.3 Biotech Companies
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cell Angiogenesis Assay Market Perspective (2017-2028)
2.2 Cell Angiogenesis Assay Growth Trends by Region
2.2.1 Cell Angiogenesis Assay Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Cell Angiogenesis Assay Historic Market Size by Region (2017-2022)
2.2.3 Cell Angiogenesis Assay Forecasted Market Size by Region (2023-2028)
2.3 Cell Angiogenesis Assay Market Dynamics
2.3.1 Cell Angiogenesis Assay Industry Trends
2.3.2 Cell Angiogenesis Assay Market Drivers
2.3.3 Cell Angiogenesis Assay Market Challenges
2.3.4 Cell Angiogenesis Assay Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell Angiogenesis Assay Players by Revenue
3.1.1 Global Top Cell Angiogenesis Assay Players by Revenue (2017-2022)
3.1.2 Global Cell Angiogenesis Assay Revenue Market Share by Players (2017-2022)
3.2 Global Cell Angiogenesis Assay Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cell Angiogenesis Assay Revenue
3.4 Global Cell Angiogenesis Assay Market Concentration Ratio
3.4.1 Global Cell Angiogenesis Assay Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell Angiogenesis Assay Revenue in 2021
3.5 Cell Angiogenesis Assay Key Players Head office and Area Served
3.6 Key Players Cell Angiogenesis Assay Product Solution and Service
3.7 Date of Enter into Cell Angiogenesis Assay Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell Angiogenesis Assay Breakdown Data by Type
4.1 Global Cell Angiogenesis Assay Historic Market Size by Type (2017-2022)
4.2 Global Cell Angiogenesis Assay Forecasted Market Size by Type (2023-2028)
5 Cell Angiogenesis Assay Breakdown Data by Application
5.1 Global Cell Angiogenesis Assay Historic Market Size by Application (2017-2022)
5.2 Global Cell Angiogenesis Assay Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Cell Angiogenesis Assay Market Size (2017-2028)
6.2 North America Cell Angiogenesis Assay Market Size by Type
6.2.1 North America Cell Angiogenesis Assay Market Size by Type (2017-2022)
6.2.2 North America Cell Angiogenesis Assay Market Size by Type (2023-2028)
6.2.3 North America Cell Angiogenesis Assay Market Share by Type (2017-2028)
6.3 North America Cell Angiogenesis Assay Market Size by Application
6.3.1 North America Cell Angiogenesis Assay Market Size by Application (2017-2022)
6.3.2 North America Cell Angiogenesis Assay Market Size by Application (2023-2028)
6.3.3 North America Cell Angiogenesis Assay Market Share by Application (2017-2028)
6.4 North America Cell Angiogenesis Assay Market Size by Country
6.4.1 North America Cell Angiogenesis Assay Market Size by Country (2017-2022)
6.4.2 North America Cell Angiogenesis Assay Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Cell Angiogenesis Assay Market Size (2017-2028)
7.2 Europe Cell Angiogenesis Assay Market Size by Type
7.2.1 Europe Cell Angiogenesis Assay Market Size by Type (2017-2022)
7.2.2 Europe Cell Angiogenesis Assay Market Size by Type (2023-2028)
7.2.3 Europe Cell Angiogenesis Assay Market Share by Type (2017-2028)
7.3 Europe Cell Angiogenesis Assay Market Size by Application
7.3.1 Europe Cell Angiogenesis Assay Market Size by Application (2017-2022)
7.3.2 Europe Cell Angiogenesis Assay Market Size by Application (2023-2028)
7.3.3 Europe Cell Angiogenesis Assay Market Share by Application (2017-2028)
7.4 Europe Cell Angiogenesis Assay Market Size by Country
7.4.1 Europe Cell Angiogenesis Assay Market Size by Country (2017-2022)
7.4.2 Europe Cell Angiogenesis Assay Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cell Angiogenesis Assay Market Size (2017-2028)
8.2 Asia-Pacific Cell Angiogenesis Assay Market Size by Type
8.2.1 Asia-Pacific Cell Angiogenesis Assay Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Cell Angiogenesis Assay Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Cell Angiogenesis Assay Market Share by Type (2017-2028)
8.3 Asia-Pacific Cell Angiogenesis Assay Market Size by Application
8.3.1 Asia-Pacific Cell Angiogenesis Assay Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Cell Angiogenesis Assay Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Cell Angiogenesis Assay Market Share by Application (2017-2028)
8.4 Asia-Pacific Cell Angiogenesis Assay Market Size by Region
8.4.1 Asia-Pacific Cell Angiogenesis Assay Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Cell Angiogenesis Assay Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Cell Angiogenesis Assay Market Size (2017-2028)
9.2 Latin America Cell Angiogenesis Assay Market Size by Type
9.2.1 Latin America Cell Angiogenesis Assay Market Size by Type (2017-2022)
9.2.2 Latin America Cell Angiogenesis Assay Market Size by Type (2023-2028)
9.2.3 Latin America Cell Angiogenesis Assay Market Share by Type (2017-2028)
9.3 Latin America Cell Angiogenesis Assay Market Size by Application
9.3.1 Latin America Cell Angiogenesis Assay Market Size by Application (2017-2022)
9.3.2 Latin America Cell Angiogenesis Assay Market Size by Application (2023-2028)
9.3.3 Latin America Cell Angiogenesis Assay Market Share by Application (2017-2028)
9.4 Latin America Cell Angiogenesis Assay Market Size by Country
9.4.1 Latin America Cell Angiogenesis Assay Market Size by Country (2017-2022)
9.4.2 Latin America Cell Angiogenesis Assay Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell Angiogenesis Assay Market Size (2017-2028)
10.2 Middle East & Africa Cell Angiogenesis Assay Market Size by Type
10.2.1 Middle East & Africa Cell Angiogenesis Assay Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Cell Angiogenesis Assay Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Cell Angiogenesis Assay Market Share by Type (2017-2028)
10.3 Middle East & Africa Cell Angiogenesis Assay Market Size by Application
10.3.1 Middle East & Africa Cell Angiogenesis Assay Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Cell Angiogenesis Assay Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Cell Angiogenesis Assay Market Share by Application (2017-2028)
10.4 Middle East & Africa Cell Angiogenesis Assay Market Size by Country
10.4.1 Middle East & Africa Cell Angiogenesis Assay Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Cell Angiogenesis Assay Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abcam
11.1.1 Abcam Company Details
11.1.2 Abcam Business Overview
11.1.3 Abcam Cell Angiogenesis Assay Introduction
11.1.4 Abcam Revenue in Cell Angiogenesis Assay Business (2017-2022)
11.1.5 Abcam Recent Developments
11.2 Bio-Techne
11.2.1 Bio-Techne Company Details
11.2.2 Bio-Techne Business Overview
11.2.3 Bio-Techne Cell Angiogenesis Assay Introduction
11.2.4 Bio-Techne Revenue in Cell Angiogenesis Assay Business (2017-2022)
11.2.5 Bio-Techne Recent Developments
11.3 Thermo Fisher
11.3.1 Thermo Fisher Company Details
11.3.2 Thermo Fisher Business Overview
11.3.3 Thermo Fisher Cell Angiogenesis Assay Introduction
11.3.4 Thermo Fisher Revenue in Cell Angiogenesis Assay Business (2017-2022)
11.3.5 Thermo Fisher Recent Developments
11.4 Cell Biolabs, Inc.
11.4.1 Cell Biolabs, Inc. Company Details
11.4.2 Cell Biolabs, Inc. Business Overview
11.4.3 Cell Biolabs, Inc. Cell Angiogenesis Assay Introduction
11.4.4 Cell Biolabs, Inc. Revenue in Cell Angiogenesis Assay Business (2017-2022)
11.4.5 Cell Biolabs, Inc. Recent Developments
11.5 BioVision, Inc
11.5.1 BioVision, Inc Company Details
11.5.2 BioVision, Inc Business Overview
11.5.3 BioVision, Inc Cell Angiogenesis Assay Introduction
11.5.4 BioVision, Inc Revenue in Cell Angiogenesis Assay Business (2017-2022)
11.5.5 BioVision, Inc Recent Developments
11.6 PromoCell GmbH
11.6.1 PromoCell GmbH Company Details
11.6.2 PromoCell GmbH Business Overview
11.6.3 PromoCell GmbH Cell Angiogenesis Assay Introduction
11.6.4 PromoCell GmbH Revenue in Cell Angiogenesis Assay Business (2017-2022)
11.6.5 PromoCell GmbH Recent Developments
11.7 Merck KGaA
11.7.1 Merck KGaA Company Details
11.7.2 Merck KGaA Business Overview
11.7.3 Merck KGaA Cell Angiogenesis Assay Introduction
11.7.4 Merck KGaA Revenue in Cell Angiogenesis Assay Business (2017-2022)
11.7.5 Merck KGaA Recent Developments
11.8 Kollodis BioSciences
11.8.1 Kollodis BioSciences Company Details
11.8.2 Kollodis BioSciences Business Overview
11.8.3 Kollodis BioSciences Cell Angiogenesis Assay Introduction
11.8.4 Kollodis BioSciences Revenue in Cell Angiogenesis Assay Business (2017-2022)
11.8.5 Kollodis BioSciences Recent Developments
11.9 Sartorius (Essen BioScience)
11.9.1 Sartorius (Essen BioScience) Company Details
11.9.2 Sartorius (Essen BioScience) Business Overview
11.9.3 Sartorius (Essen BioScience) Cell Angiogenesis Assay Introduction
11.9.4 Sartorius (Essen BioScience) Revenue in Cell Angiogenesis Assay Business (2017-2022)
11.9.5 Sartorius (Essen BioScience) Recent Developments
11.10 Creative Bioarray
11.10.1 Creative Bioarray Company Details
11.10.2 Creative Bioarray Business Overview
11.10.3 Creative Bioarray Cell Angiogenesis Assay Introduction
11.10.4 Creative Bioarray Revenue in Cell Angiogenesis Assay Business (2017-2022)
11.10.5 Creative Bioarray Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer